KEY
58
-2
FLR
65
10
CHD
42
2
KMX
47
-6
FCX
42
6
ACN
47
-5
KMI
61
4
AA
34
2
AEP
59
3
AMAT
54
-4
EXPD
26
-3
NWL
33
-2
CCI
30
2
XRX
23
-9
URBN
84
9
O
39
4
K
59
6
ADSK
62
-3
AMP
61
-2
SYY
44
-3
KEY
58
-2
FLR
65
10
CHD
42
2
KMX
47
-6
FCX
42
6
ACN
47
-5
KMI
61
4
AA
34
2
AEP
59
3
AMAT
54
-4
EXPD
26
-3
NWL
33
-2
CCI
30
2
XRX
23
-9
URBN
84
9
O
39
4
K
59
6
ADSK
62
-3
AMP
61
-2
SYY
44
-3
Financhill
Sell
45

BPMC Quote, Financials, Valuation and Earnings

Last price:
$100.07
Seasonality move :
4.62%
Day range:
$98.25 - $101.70
52-week range:
$73.04 - $121.90
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
11.57x
P/B ratio:
19.16x
Volume:
353.3K
Avg. volume:
824.2K
1-year change:
-0.87%
Market cap:
$6.6B
Revenue:
$508.8M
EPS (TTM):
-$2.47

Blueprint Medicines SEC Filings

Company Filed Form Type Description
BPMC
Blueprint Medicines
 10/26/2023 10-Q 10-Q filing on 10/26/2023 View Form
BPMC
Blueprint Medicines
 08/02/2023 10-Q 10-Q filing on 08/02/2023 View Form
BPMC
Blueprint Medicines
 05/04/2023 10-Q 10-Q filing on 05/04/2023 View Form
BPMC
Blueprint Medicines
 11/01/2022 10-Q 10-Q filing on 11/01/2022 View Form
BPMC
Blueprint Medicines
 08/02/2022 10-Q 10-Q filing on 08/02/2022 View Form
BPMC
Blueprint Medicines
 05/03/2022 10-Q 10-Q filing on 05/03/2022 View Form
BPMC
Blueprint Medicines
 10/28/2021 10-Q 10-Q filing on 10/28/2021 View Form
BPMC
Blueprint Medicines
 07/29/2021 10-Q 10-Q filing on 07/29/2021 View Form
BPMC
Blueprint Medicines
 04/29/2021 10-Q 10-Q filing on 04/29/2021 View Form
BPMC
Blueprint Medicines
 10/29/2020 10-Q 10-Q filing on 10/29/2020 View Form
BPMC
Blueprint Medicines
 07/31/2020 10-Q 10-Q filing on 07/31/2020 View Form
BPMC
Blueprint Medicines
 07/30/2020 10-Q 10-Q filing on 07/30/2020 View Form
BPMC
Blueprint Medicines
 05/06/2020 10-Q 10-Q filing on 05/06/2020 View Form
BPMC
Blueprint Medicines
 02/13/2020 10-K 10-K filing on 02/13/2020 View Form
BPMC
Blueprint Medicines
 11/05/2019 10-Q 10-Q filing on 11/05/2019 View Form
BPMC
Blueprint Medicines
 08/01/2019 10-Q 10-Q filing on 08/01/2019 View Form
BPMC
Blueprint Medicines
 05/09/2019 10-Q 10-Q filing on 05/09/2019 View Form
BPMC
Blueprint Medicines
 02/26/2019 10-K 10-K filing on 02/26/2019 View Form
BPMC
Blueprint Medicines
 10/30/2018 10-Q 10-Q filing on 10/30/2018 View Form
BPMC
Blueprint Medicines
 08/01/2018 10-Q 10-Q filing on 08/01/2018 View Form
BPMC
Blueprint Medicines
 08/01/2018 10-K 10-K filing on 08/01/2018 View Form
BPMC
Blueprint Medicines
 05/02/2018 10-Q 10-Q filing on 05/02/2018 View Form
BPMC
Blueprint Medicines
 02/21/2018 10-K 10-K filing on 02/21/2018 View Form
BPMC
Blueprint Medicines
 10/31/2017 10-Q 10-Q filing on 10/31/2017 View Form
BPMC
Blueprint Medicines
 08/02/2017 10-Q 10-Q filing on 08/02/2017 View Form
BPMC
Blueprint Medicines
 05/03/2017 10-Q 10-Q filing on 05/03/2017 View Form
BPMC
Blueprint Medicines
 03/09/2017 10-K 10-K filing on 03/09/2017 View Form
BPMC
Blueprint Medicines
 11/10/2016 10-Q 10-Q filing on 11/10/2016 View Form
BPMC
Blueprint Medicines
 08/09/2016 10-Q 10-Q filing on 08/09/2016 View Form
BPMC
Blueprint Medicines
 07/22/2016 10-Q 10-Q filing on 07/22/2016 View Form
BPMC
Blueprint Medicines
 05/10/2016 10-Q 10-Q filing on 05/10/2016 View Form
BPMC
Blueprint Medicines
 03/11/2016 10-K 10-K filing on 03/11/2016 View Form
BPMC
Blueprint Medicines
 11/09/2015 10-Q 10-Q filing on 11/09/2015 View Form
BPMC
Blueprint Medicines
 08/10/2015 10-Q 10-Q filing on 08/10/2015 View Form
BPMC
Blueprint Medicines
 06/11/2015 10-Q 10-Q filing on 06/11/2015 View Form

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Free Training Webinar

Related Companies

Get BPMC Stock Alert

Signup to receive the latest stock alerts

Financial Ratios

BPMC
Sector
P/E ratio
--
24.22x
PEG ratio
--
0.00x
P/B ratio
19.16x
1.71x
Price / LTM sales
11.57x
1.60x

Growth Metrics

BPMC
Sector
Revenue growth
55.45%
4.98%
Earnings growth
-99.29%
7.63%
Revenue (5-year growth)
50.22%
8.25%
Earnings forecast
-$0.44
-$0.20

Profitability

BPMC
Sector
Profitability FY 2024
$488.7M
$51.3M
Return on invested capital
-23.09%
-14.98%
Return on assets
-13.39%
-12.07%
Return on equity
-49.13%
-17.04%

Earnings Date

Last Earnings Date
May
1
Next Earnings Date
Aug
1
Estimated Next Earnings Date
Jul
31

Balance Sheet

BPMC
Sector
Total cash
$576.2M
$38.5M
Short term investments
$513.5M
$33.2M
Total assets
$1.2B
$118.8M
Long term debt
$387.7M
$8.3M

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Free Training Webinar

Popular

Where Will Palo Alto Networks Stock Be in 5 Years?
Where Will Palo Alto Networks Stock Be in 5 Years?

You know those companies that just refuse to slow down…

Read article
UPS Stock Forecast: Is the 6.9% Dividend Too Good to Be True?
UPS Stock Forecast: Is the 6.9% Dividend Too Good to Be True?

Parcel delivery giant UPS (NYSE:UPS) has seen its fair share…

Read article
Where Will Coinbase Stock Be in 5 Years?
Where Will Coinbase Stock Be in 5 Years?

If you’ve been anywhere near the crypto world over the…

Read article

Stock Ideas

Buy
65
Is MSFT Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 38x

Buy or Sell?
Buy
65
Is NVDA Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 45x

Buy or Sell?
Sell
33
Is AAPL Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 32x

Buy or Sell?

Alerts

Buy
55
SBET alert for May 27

SharpLink Gaming [SBET] is up 454.46% over the past day.

Buy or Sell?
Buy
57
RGC alert for May 27

Regencell Bioscience Holdings [RGC] is down 9.77% over the past day.

Buy or Sell?
Buy
90
OKLO alert for May 27

Oklo [OKLO] is up 10.05% over the past day.

Buy or Sell?
Master Safe Stock Market Strategies
Get Paid To Own Stocks. Insure Your Stocks During Downtrends. Master "The Vacation Trade".

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock

Watchlist

Stock Score

Seasonality

Analyze

Covered Calls

Valuation

Smart Money

Education

E-Book

Newsletters

Companies

Dividends

Traders Library

Big Movers

Stock Ideas